ObesityNCT04711577
Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management
A study testing Track clinician-determined symptoms and Track clinician-determined and self-determined symptoms in people with Obesity and Binge Eating, run by Northwestern University at 1 site in United States.
Trial summary
The purpose of this study is to understand users' experiences and interests completing self-tracking in a mobile intervention for binge eating and weight management. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Obesity, Binge Eating
- What is being tested?
- Track clinician-determined symptoms and Track clinician-determined and self-determined symptoms
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jan 2021to 11 Feb 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults age 18 years or older
- Obesity (BMI ≥30)
- Recurrent binge eating (≥12 episodes in the past 3 months)
- Interested in losing weight and reducing binge eating
- Willing to use a mobile application
- Willing to practice self-monitoring
Show all 9Show fewer
- Has access to a scale
- Not pregnant
- English-speaking
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to understand users' experiences and interests completing self-tracking in a mobile intervention for binge eating and weight management.
- Conditions
- Obesity, Binge Eating
- Being tested
- Track clinician-determined symptoms, Track clinician-determined and self-determined symptoms
- Medical subject headings
- Obesity, Bulimia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Track clinician-determined symptomsBehavioural
Participants will track clinician-determined symptoms
Track clinician-determined and self-determined symptomsBehavioural
Participants will track clinician-determined symptoms and a self-determined symptom
| Study group | Role | What they receive |
|---|---|---|
| Condition 1 | Experimental | Track clinician-determined symptoms Receives: Behavioral: Track clinician-determined symptoms |
| Condition 2 | Experimental | Track clinician-determined and self-determined symptoms Receives: Behavioral: Track clinician-determined and self-determined symptoms |
What is being measured
The primary outcome is the main question the study is designed to answer.
Compliance
Number of tracking entries completed
Measured: 3 weeks
Satisfaction with tracking
Self-reported satisfaction with tracking, based on the Satisfaction subscale of the Usefulness, Satisfaction, and Ease of use (USE) Questionnaire, with higher scores on the 1-7 rating scale indicating greater satisfaction
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2021
- Study start8 Jan 2021
- Primary completion11 Feb 2021
- Study completion11 Feb 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Andrea Graham, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04711577
- Sponsor's protocol ID
- STU00213531
- Status last verified
- Feb 2021
- First submitted
- 13 Jan 2021
- Last updated
- 26 Feb 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Feb 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management
- ClinicalTrials.gov ID
- NCT04711577
- Acronym / sponsor ID
- STU00213531
- Conditions
- Obesity, Binge Eating
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Northwestern UniversityUniversity, hospital or other
- Study start
- 8 Jan 2021 (actual)
- Primary completion
- 11 Feb 2021 (actual)
- Study completion
- 11 Feb 2021 (actual)
- First posted
- 15 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to understand users' experiences and interests completing self-tracking in a mobile intervention for binge eating and weight management.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Condition 1 | Experimental | Behavioral: Track clinician-determined symptomsTrack clinician-determined symptoms |
| Condition 2 | Experimental | Behavioral: Track clinician-determined and self-determined symptomsTrack clinician-determined and self-determined symptoms |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Adults age 18 years or older
- Obesity (BMI ≥30)
- Recurrent binge eating (≥12 episodes in the past 3 months)
- Interested in losing weight and reducing binge eating
- Willing to use a mobile application
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Track clinician-determined symptomsParticipants will track clinician-determined symptoms | Behavioural | Condition 1 |
| Track clinician-determined and self-determined symptomsParticipants will track clinician-determined symptoms and a self-determined symptom | Behavioural | Condition 2 |
Primary outcome
Compliance
Time frame: 3 weeks
Number of tracking entries completed
Satisfaction with tracking
Time frame: 3 weeks
Self-reported satisfaction with tracking, based on the Satisfaction subscale of the Usefulness, Satisfaction, and Ease of use (USE) Questionnaire, with higher scores on the 1-7 rating scale indicating greater satisfaction
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Feb 2021.
Related trials for Obesity
RecruitingObservational study
Diabetes and Heart Disease Risk in Blacks
Cardiovascular Diseases, Diabetes
Active, not recruitingPhase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
Electric Stimulation Therapy, Obesity
RecruitingObservational study
Children s Growth and Behavior Study
Obesity, Eating Behaviors
Recruiting
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
Obesity
Active, not recruiting
Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients
Obesity, Morbid, Eating Disorder Symptom
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Track clinician-determined symptoms and Track clinician-determined and self-determined symptoms in people with Obesity and Binge Eating, run by Northwestern University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Compliance (time frame: 3 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2021; AzTrials last refreshed its copy on 30 Oct 2026.